Combining evidence and experience in pulmonary hypertension

Humbert M., Rubin L. J.

Source: Eur Respir Rev 2009; 18: 135-136

Journal Issue: September 2009 - 18 (113)

For technical reasons, this interactive material needs to open in a new window.
Please allow pop-ups from ers-education.org.
If the window did not open automatically, please click here.

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Humbert M., Rubin L. J.. Combining evidence and experience in pulmonary hypertension. Eur Respir Rev 2009; 18: 135-136

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

The importance of patient perspectives in pulmonary hypertension Source: Eur Respir J, 53 (1) 1801919; 10.1183/13993003.01919-2018 Year: 2019
Combined treatment in pulmonary hypertension Source: International Congress 2016 – GR3 Scientific Grand Round: precision medicine Year: 2016
Comparison of clinical characteristics in patients with pulmonary arterial hypertension and inoperable chronic thromboembolic pulmonary hypertension Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008
The new definition of pulmonary hypertension Source: Eur Respir J 2009; 34: 790-791 Year: 2009
Real-life data on the medical therapy of pulmonary arterial and chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – PAH and CTEPH Year: 2017
Update on current treatment options of pulmonary hypertension Source: Annual Congress 2006 - Pulmonary hypertension at the crossroads of science and clinical medicine Year: 2006
Capillaroscopic findings in patients with pulmonary arterial hypertension Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018
Genetic findings in patients with different forms of pulmonary hypertension Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension Year: 2020
Effect of selexipag on long-term outcomes in key subgroups of patients with pulmonary arterial hypertension (PAH): GRIPHON study results Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015
Early diagnostic evaluation of pulmonary hypertension in severe COPD patients (preliminary results) Source: Eur Respir J 2006; 28: Suppl. 50, 657s Year: 2006
Integrating haemodynamics identifies an extreme pulmonary hypertension phenotype Source: Eur Respir J, 58 (2) 2004625; 10.1183/13993003.04625-2020 Year: 2021
Ergospirometry findings in patients with scleroderma in relation to concurrent pulmonary hypertension Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases Year: 2010
A paradigm shift in pulmonary arterial hypertension management Source: Eur Respir Rev 2013; 22: 423-426 Year: 2013
Contemporary pathology of pulmonary hypertension Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020
Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science Source: Eur Respir J 2016; 47:1615-1617 Year: 2016
Combining physiology and imaging in the diagnosis of pulmonary hypertension Source: International Congress 2019 – Breathing disorders, cardiovascular disease and pulmonary embolism guidelines Year: 2019
Challenging the concept of adding more drugs in pulmonary arterial hypertension Source: Eur Respir J, 50 (3) 1701527; 10.1183/13993003.01527-2017 Year: 2017